EWEdwards Lifesciences EW · NYSE
$94.15 -0.31% (-$0.29)
- Market cap
- $54.4B
- Enterprise value
- $52.2B
- P/E
- 54.1x
- Forward P/E
- 30.9x
- PEG
- -
- P/S
- 8.4x
- P/FCF
- 38.0x
- EV/EBITDA
- 33.9x
- ROIC
- 10.2%
- Gross margin
- 78.0%
- Net margin
- 15.4%
- Dividend yield
- -
- Payout ratio
- -
- Net debt/EBITDA
- -1.4x
- Beta
- 0.86
- Free float
- 98.8%
About the company
Edwards Lifesciences Corporation is an American company headquartered in Irvine, California. It specializes in the development, manufacturing, and sale of medical devices and technologies focused on the treatment of cardiovascular diseases. Their main products include innovative devices for surgical and interventional treatments of the heart and blood vessels, including valve replacements, surgical revascularization devices, monitoring systems, and more. Edwards Lifesciences Corporation is known for its advanced technologies and innovative products that contribute to the treatment of patients with cardiovascular diseases and improve their quality of life. The company has a global presence and is recognized as a leader in the field of cardiovascular medical technologies. Shares of Edwards Lifesciences Corporation are publicly traded on the NASDAQ stock exchange.
Sector
Healthcare
Industry
Medical - Devices
CEO
Bernard J. Zovighian
Employees
16,000
Headquarters
Irvine
Valuation
Is today's price reasonable?
- What to watch: The share price is above the Bulios Fair Price.
Growth and estimates
Is it growing, and what comes next?
- What speaks for it: Analysts expect revenue to grow by 12% this fiscal year.
- What to watch: Earnings per share fell by 9.1% a year over the last 3 years.
Profitability and quality
How much of the revenue is left, and how well does the company use its capital?
- What speaks for it: Out of every 100 USD of revenue, 15 USD is left as net profit.
Financial health
Can it carry its debt?
- What speaks for it: It holds more cash than debt: $2.91B against $704.4M.
Capital and dividends
What does the company do with the money it earns?
Analysts
What do the professionals think, and is it changing?
Owners and insiders
Who holds the stock, and what is management doing?
Segments
Which part of the company is growing?
Peer comparison
How does it compare with similar companies?
Price and risk
How does the stock behave?
Statements
Every number